Drug Index


Mechanism :

Tacalcitol is a vitamin D3 derivative. It binds to the keratinocyte vitamin D receptor to the same extent as the natural vitamin D3. It acts by normalising cell growth and development in the skin. It prevents the excessive growth rate of skin cells that leads to scaling of the skin characteristic of psoriasis.

Indication :

  • Psoriasis vulgaris

Contraindications :

Contraindicated in known hypersensitivity and in disorders of calcium metabolism, monitor serum calcium in patients at risk of hypercalcemia and in renal impairment.

Dosing :

12-18 years:
Apply sparingly at bedtime.

Adverse Effect :

Frequently seen adverse reactions include local skin reactions, itching, erythema, burning, paresthesia, hypercalcaemia, contact dermatitis, burning sensation and irritation in area of use.

Interaction :

Patients may take up 500 international units of vitamin D in multivitamin preparations. Ultra-violet light including sunlight may degrade tacalcitol, hence apply at bedtime.

Hepatic Dose :

No dosage adjustments are recommended.
01/21/2024 09:52:13 Tacalcitol
Disclaimer: The information given by www.pediatriconcall.com is provided by medical and paramedical & Health providers voluntarily for display & is meant only for informational purpose. The site does not guarantee the accuracy or authenticity of the information. Use of any information is solely at the user's own risk. The appearance of advertisement or product information in the various section in the website does not constitute an endorsement or approval by Pediatric Oncall of the quality or value of the said product or of claims made by its manufacturer.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0